(Q33611567)

28 July 2017

title

Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease (English)

1 reference

28 July 2017

0 references

1 reference

congestive heart failure

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

Sueta CA

1

1 reference

28 July 2017

Chowdhury M

2

1 reference

28 July 2017

Boccuzzi SJ

3

1 reference

28 July 2017

Smith SC Jr

4

1 reference

28 July 2017

Alexander CM

5

1 reference

28 July 2017

Londhe A

6

1 reference

28 July 2017

Lulla A

7

1 reference

28 July 2017

Simpson RJ Jr

8

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

American Journal of Cardiology

28 July 2017

published in

1 reference

28 July 2017

volume

83

1 reference

28 July 2017

issue

9

1 reference

28 July 2017

page(s)

1303-1307

1 reference

ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900117-4

The epidemiology of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900117-4

Variations in cholesterol management practices of U.S. physicians.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900117-4

Low incidence of assessment and modification of risk factors in acute care patients at high risk for cardiovascular events, particularly among females and the elderly. The Clinical Quality Improvement Network (CQIN) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900117-4

Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900117-4

Angiotensin-converting-enzyme inhibitors in the management of cardiac failure: are we ignoring the evidence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900117-4

Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900117-4

Performance assessment model for guideline-recommended pharmacotherapy in the secondary prevention of coronary artery disease and treatment of left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900117-4

ASHP therapeutic guidelines on angiotensin-converting-enzyme inhibitors in patients with left ventricular dysfunction. This official ASHP practice standard was developed through the ASHP Commission on Therapeutics and approved by the ASHP Board of D

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900117-4

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900117-4

Inadequate management of hyperlipidaemia after coronary bypass surgery shown by medical audit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900117-4

Cholesterol awareness and treatment in patients with coronary artery disease participating in cardiac rehabilitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900117-4

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900117-4

Inadequate treatment with HMG-CoA reductase inhibitors by health care providers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900117-4

Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900117-4

Patterns of medication use in patients with heart failure: a report from the Registry of Studies of Left Ventricular Dysfunction (SOLVD).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900117-4

10.1016/S0002-9149(99)00117-4

7 January 2021

Identifiers

DOI

1 reference

release_bqljdgq3abgpbowsur6btkugau

28 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bqljdgq3abgpbowsur6btkugau

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference